Atria Investments Inc Lowers Stock Position in UnitedHealth Group Incorporated $UNH

Atria Investments Inc lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 25.5% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 55,416 shares of the healthcare conglomerate’s stock after selling 19,002 shares during the period. Atria Investments Inc’s holdings in UnitedHealth Group were worth $17,288,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Bayforest Capital Ltd boosted its stake in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd increased its position in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares during the period. O Brien Wealth Partners LLC grew its stake in UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after purchasing an additional 37 shares in the last quarter. Nova Wealth Management Inc. grew its position in shares of UnitedHealth Group by 339.1% during the first quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock worth $53,000 after buying an additional 78 shares in the last quarter. Finally, Cloud Capital Management LLC purchased a new position in UnitedHealth Group in the first quarter worth approximately $53,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 3.2%

Shares of UNH stock opened at $356.05 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The business’s 50 day moving average is $342.00 and its two-hundred day moving average is $331.00. The company has a market capitalization of $322.47 billion, a P/E ratio of 18.58, a price-to-earnings-growth ratio of 2.37 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same period last year, the company earned $7.15 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Analyst Ratings Changes

A number of equities analysts recently commented on UNH shares. Oppenheimer lowered their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. KeyCorp increased their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Leerink Partners set a $410.00 target price on shares of UnitedHealth Group and gave the company an “outperform” rating in a research report on Wednesday. Finally, Truist Financial lifted their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Eighteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $395.64.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.